Effect of a Fasting Mimicking Diet on Patients With Multiple Sclerosis (FMDMS)
50
about 2 years
18–55
1 site in CA
What this study is about
Researchers are testing if a fasting mimicking diet improves the quality of life for people with relapsing multiple sclerosis who are already taking disease-modifying therapies. The trial will compare this to a Mediterranean diet control group.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Med Diet. Investigators would like to see what differences a Mediterranean Diet makes to the status of patients with Multiple Sclerosis
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Health-related Quality of Life (HRQOL)
Secondary: Assessing Safety and Tolerability of a FMD in MS: Compliance and Serious Adverse Events, To evaluate alterations in immune function by assessing changes in cell counts, serum cytokines and secretion patterns, with a focus on pro-inflammatory cytokines IL-2, interferon-gamma (IFNγ), and IL-17A, and the regulatory cytokine, IL-10. Units: pg/mL, To evaluate the effect on clinical measures of neurological status: EDSS
Neurology